Back to Search
Start Over
Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome
- Source :
- Kidney & Blood Pressure Research, Vol 43, Iss 5, Pp 1437-1450 (2018)
- Publication Year :
- 2018
- Publisher :
- Karger Publishers, 2018.
-
Abstract
- Background/Aims: Chronic heart failure (HF) disrupts normal kidney function and leads to cardiorenal syndrome that further promotes HF progression. To identify potential participants in HF-related injury, we analyzed kidney proteome in an established HF model. Methods: HF was induced by chronic volume overload in male HanSD rats using aorto-caval fistula. After 21 weeks, cardiac and renal functions (in-situ kidney study) and renal proteomics were studied in sham-operated (controls) and HF rats, using iTRAQ labeling and LC-MS with Orbitrap Fusion, leading to identification and quantification of almost 4000 proteins. Results: Compared to controls, HF rats had cardiac hypertrophy, systemic and pulmonary congestion. Kidneys of HF rats had reduced renal blood flow, sodium excretion and urine production. While glomerular filtration rate, serum cystatin C and creatinine were still normal compared to controls, HF kidneys showed albuminuria and markedly increased tissue angiotensin-II levels (5-fold). HF kidneys (versus controls) displayed differential expression (˃1.5-fold) of 67 proteins. The most upregulated were angiotensin-converting enzyme (ACE, ˃20-fold), advanced glycosylation product-specific receptor (RAGE, 14-fold), periostin (6.8-fold), caveolin-1 (4.5-fold) and other proteins implicated in endothelial function (vWF, cavins 1-3, T-kininogen 2), proinflammatory ECM activation (MFAP4, collagen-VI, galectin-3, FHL-1, calponin) and proteins involved in glomerular filtration membrane integrity (CLIC5, ZO-1). Carboxylesterase-1D (CES1D), an enzyme that converts ACE inhibitors or sacubitril into active drugs, was also upregulated in HF kidneys. Conclusion: Chronic HF leads to latent kidney injury, associated with deep changes in kidney protein composition. These alterations may act in concert with intrarenal renin-angiotensin system activation and may serve as markers and/or targets to tackle cardiorenal syndrome.
- Subjects :
- Male
0301 basic medicine
Proteomics
lcsh:Diseases of the circulatory (Cardiovascular) system
Proteome
Receptor for Advanced Glycation End Products
030204 cardiovascular system & hematology
Kidney
lcsh:RC870-923
Renin-Angiotensin System
chemistry.chemical_compound
0302 clinical medicine
lcsh:Dermatology
Extracellular Matrix Proteins
General Medicine
Up-Regulation
medicine.anatomical_structure
Nephrology
medicine.symptom
Cardiology and Cardiovascular Medicine
medicine.medical_specialty
Cardiorenal syndrome
Renal function
Cardiomegaly
Heart failure
Peptidyl-Dipeptidase A
03 medical and health sciences
Kidney function
Internal medicine
medicine
Albuminuria
Animals
Endothelium
Creatinine
Cardio-Renal Syndrome
business.industry
lcsh:RL1-803
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
Angiotensin II
Rats
030104 developmental biology
Endocrinology
chemistry
lcsh:RC666-701
Renal blood flow
Angiotensin-II
business
Subjects
Details
- Language :
- English
- ISSN :
- 14230143 and 14204096
- Volume :
- 43
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Kidney & Blood Pressure Research
- Accession number :
- edsair.doi.dedup.....3391ba8c475e34ea4898b2a873398769